Skip to content
PolyBio Industries Ltd. Farm-to-Pharma · Industrial Biotechnology

Products

The product architecture,
honestly labelled

Every entry below carries its real development status. Nothing here is offered for commercial sale today.

Current In commercial production and available for sale today.
In development Engineering, financing or regulatory work is underway. Not yet available for sale.
Future platform Part of the platform architecture. Not in development as a commercial product yet.

Phase 1

Phase 1

The first production line under development.

Pharmaceutical-grade native potato starch

In development

Native potato starch produced to pharmaceutical specification for use as an excipient, and to food and industrial grades from the same line.

  • Excipient applications
  • Food-grade applications
  • Industrial applications
  • Import substitution

Co-product recovery

Co-product recovery

Streams that leave the Phase 1 process and are designed to be recovered rather than discharged.

Potato protein

Future platform

Protein recovered from potato fruit juice for nutrition and feed applications.

  • Feed protein
  • Nutritional applications

Potato pulp / agro-nutrition

Future platform

Fibre-rich co-product directed to animal feed and agro-nutrition rather than waste.

  • Animal feed
  • Agro-nutrition

Organic fertiliser

Future platform

Nutrient recovery from organic residue streams, returning nutrients to farmland.

  • Soil nutrition
  • Circular return to farm

Biogas / energy recovery

Future platform

Energy recovery from process residues to reduce external energy demand at the plant.

  • Process energy
  • Emission reduction

Platform extension

Platform extension

Products the platform is architected to add. None is in production and none is offered for sale.

Modified starches

Future platform

Functionally modified grades for specified industrial and pharmaceutical performance.

  • Cross-linked
  • Acid-thinned
  • Carboxymethyl

Pregelatinised starch

Future platform

Cold-water-soluble grades for direct compression and instant applications.

  • Direct compression
  • Instant applications

Pharmaceutical-grade maize starch

Future platform

A second raw-material base for the same refining platform.

  • Second feedstock

Dextrose, glucose syrup, maltodextrin

Future platform

Starch-derived sweetener and carrier products.

  • Food industry
  • Pharmaceutical carriers

Pharmaceutical & industrial excipients

Future platform

A broader excipient portfolio built on the refining base.

  • Excipient portfolio

Other bio-based ingredients

Future platform

Further biotechnology-based agricultural and industrial ingredients.

  • Platform extension

Status notice. No PolyBio product is available for commercial sale at this time. Product names, grades and applications describe the platform architecture and Phase 1 design, not an existing catalogue. No pharmacopoeial, GMP or export certification is claimed.